1-5 of 5
Barbara Ferstl
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Alnuctamab (ALNUC; BMS-986349; CC-93269), a B-Cell Maturation Antigen (BCMA) x CD3 T-Cell Engager (TCE), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from a Phase 1 First-in-Human Clinical Study

Sandy W. Wong, Noffar Bar, Laura Paris, Craig C Hofmeister, Markus Hansson, Armando Santoro, Maria-Victoria Mateos, Paula Rodríguez-Otero, Johan Lund, Cristina Encinas, Andrew J. Yee, Albert Oriol, Claudio Cerchione, Javier de la Rubia, Barbara Ferstl, Kristina Carlson, Paz Ribas, Arancha Bermúdez, Isaac W. Boss, Allison Gaudy, Shaoyi Li, Kevin Hsu, Colin D. Godwin, Michael R. Burgess, Jesús San-Miguel, Luciano J. Costa
Journal: Blood
Blood (2022) 140 (Supplement 1): 400–402.
https://doi.org/10.1182/blood-2022-159009
Published: 2022
Journal Articles

MOR202 with Low-Dose Dexamethasone (Dex) or Pomalidomide/Dex or Lenalidomide/Dex in Relapsed or Refractory Multiple Myeloma (RRMM): Primary Analysis of a Phase I/IIa, Multicenter, Dose-Escalation Study

Marc S Raab, MD PhD, Manik Chatterjee, MD, Hartmut Goldschmidt, MD, Hermine Agis, MD, Igor Blau, MD PhD, Hermann Einsele, MD, Monika Engelhardt, MD, Barbara Ferstl, MD, Martin Gramatzki, MD, Christoph Rollig, MD MSC, Katja Weisel, MD, Tiantom Jarutat, MD, Dominika Weinelt, MD, Mark Winderlich, PhD, Christian Peschel, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 153.
https://doi.org/10.1182/blood-2018-153
Published: 2018
Journal Articles

A Phase I/IIa Study of the CD38 Antibody MOR202 Alone and in Combination with Pomalidomide or Lenalidomide in Patients with Relapsed or Refractory Multiple Myeloma

Marc S. Raab, MD, Manik Chatterjee, MD, Hartmut Goldschmidt, MD, Hermine Agis, MD, Igor Blau, Hermann Einsele, MD, Monika Engelhardt, MD PhD, Barbara Ferstl, MD, Martin Gramatzki, MD, Christoph Röllig, MD, Katja Weisel, MD, Tiantom Jarutat, MD, Dominika Weinelt, MD, Jan Endell, PhD, Rainer Boxhammer, PhD, Christian Peschel, MD
Journal: Blood
Blood (2016) 128 (22): 1152.
https://doi.org/10.1182/blood.V128.22.1152.1152
Published: 2016
Journal Articles

Phase I/IIa Study of the Human Anti-CD38 Antibody MOR202 (MOR03087) in Relapsed or Refractory Multiple Myeloma

Marc S Raab, MD PhD, Manik Chatterjee, MD, Hartmut Goldschmidt, MD, Hermine Agis, MD, Igor W Blau, MD PhD, Hermann Einsele, MD, Monika Engelhardt, MD, Barbara Ferstl, MD, Martin Gramatzki, MD, Christoph Röllig, MD, Katja C. Weisel, Pia Klöpfer, MD, Dominika Weinelt, MD, Stefan Härtle, PhD, Christian Peschel, MD
Journal: Blood
Blood (2015) 126 (23): 3035.
https://doi.org/10.1182/blood.V126.23.3035.3035
Published: 2015
Journal Articles

Blinatumomab Monotherapy Shows Efficacy in Patients with Relapsed Diffuse Large B Cell Lymphoma

Andreas Viardot, MD, Mariele Goebeler, MD, Richard Noppeney, MD, Stefan W. Krause, MD, Stefan Kallert, MD, Barbara Ferstl, MD, Andreas Mackensen, Kathrin Rupertus, MD, Martin Soekler, MD, Lothar Kanz, MD, Stefan Knop, MD, Max S. Topp, MD, Jurgen Scheele, MD, PhD, Dirk Nagorsen, MD, Gerhard Zugmaier, MD, Evelyn Degenhard, Margit Schmidt, PhD, Peter Kufer, MD, Martin Libicher, MD, Hermann Einsele, MD, Ralf Bargou, MD
Journal: Blood
Blood (2011) 118 (21): 1637.
https://doi.org/10.1182/blood.V118.21.1637.1637
Published: 2011